SDZ 210086
Alternative Names: SDZ BOP 086Latest Information Update: 22 Jan 1997
At a glance
- Originator Novartis
- Class Analgesics; Antipyretics; Muscle relaxants; Nootropics
- Mechanism of Action Muscarinic M1 receptor agonists
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
Most Recent Events
- 22 Jan 1997 No-Development-Reported for Alzheimer's disease in Switzerland (Unknown route)